Medical and Pharmaceutical Regeneron Pharmaceuticals gets access to biometric data for 15 million people When 23andMe collapsed financially, its genetic data quickly attracted attention as a lucrative asset Joseph MortonMay 20, 2025
Medical and Pharmaceutical RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement The biotech operator can develop and commercialize Jemincare's food allergy medication throughout most of the world Rowan DunneDecember 23, 2024
Health & Wellness World Lung Day highlights need for improved lung cancer screening rates Combatting air pollution and quitting smoking are also key themes Rowan DunneSeptember 25, 2024